These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8629294)

  • 41. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
    Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients.
    Indudhara R; Khauli RB; Menon M; Stoff JS
    J Urol; 1994 Aug; 152(2 Pt 1):307-11. PubMed ID: 8015058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion to tacrolimus after liver transplantation.
    Jonas S; Bechstein WO; Lemmens HP; Kling N; Grauhan O; Lobeck H; Neuhaus P
    Transpl Int; 1996; 9(1):23-31. PubMed ID: 8748407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
    Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
    Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
    Gotti E; Perico N; Perna A; Gaspari F; Cattaneo D; Caruso R; Ferrari S; Stucchi N; Marchetti G; Abbate M; Remuzzi G
    J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
    Solomon H; Gonwa TA; Mor E; Holman MJ; Gibbs J; Watemberg I; Netto G; Goldstein RM; Husberg BS; Klintmalm GB
    Transplantation; 1993 Jan; 55(1):87-91. PubMed ID: 8420070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tacrolimus rescue therapy for children with acute renal transplant rejection.
    Hymes LC; Warshaw BL
    Pediatr Nephrol; 2001 Dec; 16(12):990-2. PubMed ID: 11793086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
    Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
    Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tacrolimus for steroid-resistant liver rejection in children.
    Jara P; Robledo MJ; Frauca E; Gonzalez-Filgueira MD; Hierro L; de la Vega A; Camarena C; Martín-Ibáñez M; Murcia J; López-Santamaría M; Larrauri J; Díaz MC; Gámez M
    Transpl Int; 1998; 11 Suppl 1():S275-7. PubMed ID: 9664996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
    Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
    Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era.
    Odorico JS; Becker YT; Groshek M; Werwinski C; Becker BN; Pirsch JD; Sollinger HW
    Cell Transplant; 2000; 9(6):919-27. PubMed ID: 11202579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.
    Laskow DA; Vincenti F; Neylan JF; Mendez R; Matas AJ
    Transplantation; 1996 Oct; 62(7):900-5. PubMed ID: 8878381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
    J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX; Ciancio G; Burke GW; Roth D; Miller J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
    Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ; First MR; Mansour ME; Alexander JW; Penn I
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.
    Oh CS; Stratta RJ; Fox BC; Sollinger HW; Belzer FO; Maki DG
    Transplantation; 1988 Jan; 45(1):68-73. PubMed ID: 3276066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
    Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
    Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.